Xiao Fucheng, Wang Jian, Wu Hengchao, Sun Hansong
Department of Cardiovascular Surgery, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital and Cardiovascular Institute, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100037, China.
Chin Med J (Engl). 2015 Jan 5;128(1):63-8. doi: 10.4103/0366-6999.147813.
The impact of sequential vein bypass grafting on clinical outcomes is less known in off-pump coronary artery bypass grafting (CABG). We aimed to evaluate the effects of sequential vein bypass grafting on clinical outcomes in off-pump CABG.
From October 2009 to September 2013 at the Fuwai Hospital, 127 patients with at least one sequential venous graft were matched with 127 patients of individual venous grafts only, using propensity score matching method to obtain risk-adjusted outcome comparison. In-hospital measurement was composite outcome of in-hospital death, myocardial infarction (MI), stroke, requirement for intra-aortic ballon pump (IABP) assistance and prolonged ventilation. Major adverse cardiac events (MACEs: Death, MI or repeat revascularization) and angina recurrence were considered as mid-term endpoints.
No significant difference was observed among the groups in baseline characteristics. Intraoperative mean blood flow per vein graft was 40.4 ml in individual venous grafts groups versus 59.5 ml in sequential venous grafts groups (P < 0.001). There were no differences between individual and sequential venous grafts groups with regard to composite outcome of in-hospital mortality, MI, stroke, IABP assistance and prolonged ventilation (11.0% vs. 14.2%, P = 0.45). Individual in-hospital measurement also did not differ significantly between the two groups. At about four years follow-up, the survival estimates free from MACEs (92.5% vs. 97.3%, P = 0.36) and survival rates free of angina recurrence (80.9% vs. 85.5%, P = 0.48) were similar among individual and sequential venous grafts groups with a mean follow-up of 22.5 months. In the Cox regression analysis, sequential vein bypass grafting was not identified as an independent predictor of both MACEs and angina recurrence.
Compared to individual vein bypass grafting, sequential vein bypass grafting was not associated with an increase of either in-hospital or mid-term adverse events in patients undergoing off-pump CABG.
在非体外循环冠状动脉旁路移植术(CABG)中,序贯静脉旁路移植术对临床结局的影响鲜为人知。我们旨在评估序贯静脉旁路移植术对非体外循环CABG临床结局的影响。
2009年10月至2013年9月期间,在阜外医院,采用倾向评分匹配法,将127例至少有一根序贯静脉移植物的患者与127例仅采用单根静脉移植物的患者进行匹配,以获得风险调整后的结局比较。住院期间测量指标为住院死亡、心肌梗死(MI)、中风、主动脉内球囊泵(IABP)辅助需求及通气时间延长的复合结局。主要不良心脏事件(MACE:死亡、MI或再次血运重建)和心绞痛复发被视为中期终点。
两组患者的基线特征无显著差异。单根静脉移植物组每根静脉移植物的术中平均血流量为40.4 ml,序贯静脉移植物组为59.5 ml(P < 0.001)。单根静脉移植物组和序贯静脉移植物组在住院死亡率、MI、中风、IABP辅助及通气时间延长的复合结局方面无差异(11.0%对14.2%,P = 0.45)。两组患者的个体住院测量指标也无显著差异。在平均随访22.5个月时,单根静脉移植物组和序贯静脉移植物组无MACE的生存估计值(92.5%对97.3%,P = 0.36)和无心绞痛复发的生存率(80.9%对85.5%,P = 0.48)相似。在Cox回归分析中,序贯静脉旁路移植术未被确定为MACE和心绞痛复发的独立预测因素。
与单根静脉旁路移植术相比,序贯静脉旁路移植术与非体外循环CABG患者的住院或中期不良事件增加无关。